MGNX earnings call for the period ending September 30, 2019.
News & Analysis: MacroGenics
With Breast Cancer Awareness Month drawing to a close and the San Antonio Breast Cancer Symposium on the horizon, stay alert for breaking news from companies developing new treatments.
Shares sink after the company provides investors with a clinical update. Here are the must-know details.
These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.
MacroGenics shares jumped in response to another major clinical update today.
These cancer drug developers could report market-moving news soon.
MGNX earnings call for the period ending March 31, 2019.
Positive results for its breast cancer drug candidate lit a fire under this small-cap biotech.
MGNX earnings call for the period ending December 31, 2018.
A positive breast cancer trial readout sent this tiny biotech's shares rocketing higher.